This study found that androgenic alopecia patients using Propecia reported a significant decrease in Quality of Life compared to those using Minoxidil, particularly in the area of emotional role limitations.
1 citations
,
January 2025 in “JEADV Clinical Practice” This study reported that the AAPPO tool effectively distinguishes between patients with alopecia areata based on scalp hair loss severity, whereas the EQ‐5D‐5L may underestimate the specific disease burden, particularly in psychological and social aspects.
43 citations
,
March 2019 in “JAMA Dermatology” This study found that persistent chemotherapy-induced alopecia is often more severe and diffuse than alopecia from endocrine therapy, with both conditions negatively impacting patients' emotional wellbeing, and moderate to significant improvement was observed with dermatologic therapy.
December 2025 in “Medicina” This study found that six months after bariatric surgery, Latvian patients experienced significant improvements in quality of life, weight loss, and resolution of some obesity-related symptoms, although hair loss was a common postoperative effect.
24 citations
,
June 2021 in “Journal of the European Academy of Dermatology and Venereology” This review highlights current knowledge about quality of life assessment in alopecia areata, noting limited use of existing instruments and a need for further validation.
